Patent granted for lead orexin-1 antagonist in addictive behaviours programme
Patent granted for lead orexin-1 antagonist in addictive behaviours programme2019-01-242019-01-24https://chronosthera.wpengine.com/wp-content/uploads/2017/09/vector-smart-object025x.pngChronos Therapeuticshttps://chronosthera.wpengine.com/wp-content/uploads/2017/09/vector-smart-object025x.png200px200px
